Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pudil

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Vnitrni Lekarstvi|May 22, 2013
[Is there any benefit in natriuretic peptide levels determination in patients without apparent heart failure?]R Pudil
Vnitrni Lekarstvi|December 2, 2009
[Natriuretic peptides, renal impairment and onset of cardiovascular complications]R Pudil, M Tichý
Archives of Internal Medicine|August 4, 2001
Severe bradycardia after a methylprednisolone "minipulse" treatmentR Pudil, Z Hrncir
Vnitrni Lekarstvi|June 8, 2006
[Is cardiotoxicity of chemotherapy a problem of the oncologist or also the cardiologist?]R Pudil, J M Horácek
Casopis Lekaru Ceskych|January 5, 2006
[Present view on the stem cell plasticity and cell therapy]S Filip, J Mokrý, R Pudil
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|January 1, 1993
[Basic indicators of cellular immunity in patients with chronic staphylococcal osteomyelitis]R Pudil, K Karpas, I Hanovcová
Casopis Lekaru Ceskych|May 13, 2005
[Contemporary view on the plasma natriuretic peptide assessment in the clinical practice]R Pudil, M Tichý, J Gregor
Vnitrni Lekarstvi|January 1, 1993
[Behçet's disease and IgG lambda paraproteinemia]R Pudil, Z Hrncír, M Tichý, et al.
Leukemia Research|February 25, 2009
Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemiaM Jakl, J M Horacek, L Jebavy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2008
Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicityJ M Horacek, M Tichy, R Pudil, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Vnitrni Lekarstvi|May 22, 2013
[Is there any benefit in natriuretic peptide levels determination in patients without apparent heart failure?]R Pudil
Vnitrni Lekarstvi|December 2, 2009
[Natriuretic peptides, renal impairment and onset of cardiovascular complications]R Pudil, M Tichý
Archives of Internal Medicine|August 4, 2001
Severe bradycardia after a methylprednisolone "minipulse" treatmentR Pudil, Z Hrncir
Vnitrni Lekarstvi|June 8, 2006
[Is cardiotoxicity of chemotherapy a problem of the oncologist or also the cardiologist?]R Pudil, J M Horácek
Casopis Lekaru Ceskych|January 5, 2006
[Present view on the stem cell plasticity and cell therapy]S Filip, J Mokrý, R Pudil
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|January 1, 1993
[Basic indicators of cellular immunity in patients with chronic staphylococcal osteomyelitis]R Pudil, K Karpas, I Hanovcová
Casopis Lekaru Ceskych|May 13, 2005
[Contemporary view on the plasma natriuretic peptide assessment in the clinical practice]R Pudil, M Tichý, J Gregor
Vnitrni Lekarstvi|January 1, 1993
[Behçet's disease and IgG lambda paraproteinemia]R Pudil, Z Hrncír, M Tichý, et al.
Leukemia Research|February 25, 2009
Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemiaM Jakl, J M Horacek, L Jebavy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2008
Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicityJ M Horacek, M Tichy, R Pudil, et al.
Pageof 5